Sales and Marketing
AstraZeneca’s trial of leukaemia drug Calquence yields positive results
December 9, 2019 Sales and Marketing AstraZeneca, Calquence, leukaemia, phase 3
Sanofi acquires biotech firm Synthorx for $2.5 billion
December 9, 2019 Sales and Marketing Genetic Alphabet, Sanofi, acute lymphoblastic leukaemia, leukaemia
Transactions in the pharma sector: Through the EU merger review looking-glass
December 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, feature, mergers & acquisitions, pharma
J&J’s CAR-T candidate boasts 100% response rate in relapsed or refractory multiple myeloma
December 9, 2019 Research and Development, Sales and Marketing ASH 2019, CAR-T, J&J, JJ, Johnson & Johnson, pharma
Top Ten most popular articles on Pharmafile.com this week
December 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, NHS, corruption, lung cancer, opiods crisis, opioids
FDA approves first three generic versions of Novartis’ Gilenya for relapsing multiple sclerosis
December 6, 2019 Medical Communications, Sales and Marketing Novartis, generics, gilenya, multiple sclerosis, pharma
Partnership with payers: Communicating and negotiating with impact
December 6, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA, market access, pharma
Amazon and Novartis team up on cloud services
December 5, 2019 Sales and Marketing Amazon Web Services, Cloud services, Novartis, amazon, pharma, product lines
Dr Richard Torbett is named as the new Chief Executive of the ABPI
December 5, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Patient experience: Living with desmoid fibromatosis
December 4, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing desmoid fibrosis, feature, patient experience, pharma, rare disease
Roche’s Tecentriq combo scores FDA approval in non-small cell lung cancer
December 4, 2019 Research and Development, Sales and Marketing FDA, NSCLC, Roche, pharma, tecentriq
Purdue Pharma’s Richard Sackler ignored OxyContin addiction concerns, new emails show
December 3, 2019 Manufacturing and Production, Sales and Marketing Opiod, Purdue Pharma, Richard Sackler, opiod crisis
AstraZeneca sells US/Canada rights for Seroquel for $41 million to “focus on main therapy areas”
December 3, 2019 Manufacturing and Production, Sales and Marketing AstraZeneca, pharma
Astellas poised to acquire neuromuscular disease specialist Audentes for $3bn all-cash
December 3, 2019 Manufacturing and Production, Sales and Marketing Astellas, Audentes, acquisition, neuromuscular disease, pharma
Dr Richard Torbett is named as the new Chief Executive of the ABPI
December 2, 2019 Sales and Marketing British pharmaceuticals, Dr Richard Corbett, apbi, appointments
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
